NCT00066677 Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00066456 Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer Status COMPLETED Phase PHASE1
NCT00066443 Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00065182 Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00064012 Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00063934 Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00062439 S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors Status COMPLETED Phase PHASE2
NCT00062270 Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00059943 Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer Status COMPLETED Phase PHASE2
NCT00058448 S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) Status TERMINATED Phase PHASE2
NCT00058253 Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors Status COMPLETED Phase PHASE1
NCT00055861 Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00055770 Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00055731 Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse Status COMPLETED Phase PHASE3
NCT00054587 Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer Status COMPLETED Phase PHASE3
NCT00054457 Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT00054275 Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer Status COMPLETED Phase PHASE2
NCT00054184 Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE3
NCT00054054 S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00053911 Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer Status TERMINATED Phase PHASE3